2024

1 Ginkgo biloba droplet pills awarded as one of the first batch. Lidocaine Hydrochloride Injection Passes the Bioequivalence and Therapeutic Efficacy Evaluation for Generic Drugs.

2 Ginkgo biloba droplet pills awarded as one of the first batch. Awarded “ 2023 "Top 20 Industrial Enterprises in Wenling City of the Year."

February, Recognized as "The Sixth Batch of Provincial-Level Employment Internship Demonstration Bases" 。

3 Ginkgo biloba droplet pills awarded as one of the first batch. The registration application for tenofovir alafenamide fumarate, the chemical API, has been approved.

3 Ginkgo biloba droplet pills awarded as one of the first batch. Praised by the National Center for Adverse Drug Reaction Monitoring, safeguarding public health.

3 Ginkgo biloba droplet pills awarded as one of the first batch. Ginkgo biloba droplet pills awarded as one of the first一批. "Zhejiang-Produced Traditional Chinese Medicine" Industry Brand 。

4 Ginkgo biloba droplet pills awarded as one of the first batch. The biphenyl dimethyl ester active pharmaceutical ingredient is supplied via South Korea. MFDS On-site inspection 。

4 Ginkgo biloba droplet pills awarded as one of the first batch. Clozapine tablets and calcium citrate tablets—two products that were among the first in China to implement age-friendly labeling instructions. "The large-print version" of the manual is now available for sale.

4 Ginkgo biloba droplet pills awarded as one of the first batch. 1 The novel traditional Chinese medicine, Zhongxiao Pi Granules, has received approval from the Ethics Committee and is now ready to commence. II Phase Clinical 。

5 Ginkgo biloba droplet pills awarded as one of the first batch. Huperzine A is used to treat neonatal hypoxic-ischemic encephalopathy. HIE ) To obtain U.S. Food and Drug Administration ( FDA) Rare pediatric diseases awarded And Orphan Drug Designation Double Recognition 。

5 Ginkgo biloba droplet pills awarded as one of the first batch. By brand strength 686 , Brand Value 18.14 Hundreds of millions of yuan, included 2024 China's brand value Review List of Independently Innovative Brand Categories ， And Brand value reaches a new record high, up from last year. 5.53% 。

5 Ginkgo biloba droplet pills awarded as one of the first batch. Ye Yang, Secretary of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences; Professor Liu Jia, Researcher; Professor Zhu Mulan from the Chenshan Science Center at the Center of Excellence in Molecular Plant Sciences, CAS; and Dr. Chen Yang from Shanghai Jin Yangguang Biotechnology, along with consultant Teacher Jin, visited Wanbangde Pharmaceutical Group to jointly discuss matters related to enhancing the company’s core products—huperzine A and Ginkgo Leaf Dropping Pills.

5 Ginkgo biloba droplet pills awarded as one of the first batch. First Postdoctoral Research Workstation Doctor Smoothly Exit , the three postdoctoral researchers at the station successfully passed Mid-term Assessment 。

6 Ginkgo biloba droplet pills awarded as one of the first batch. The seminar on projects such as the Shiguajiajia controlled-release tablets was successfully held, providing clear guidance for the product’s clinical trials and future research planning.

6 Ginkgo biloba droplet pills awarded as one of the first batch. Ginkgo biloba droplets make it onto the " 2024 Chinese Medicine ▪ Brand Ranking [Hospital Outlets] List —— Categories of Medicines for Cardiovascular and Cerebrovascular Diseases (Traditional Chinese Medicine Formulations) ”, has been ongoing for 5 Has topped the list for consecutive years.

8 Ginkgo biloba droplet pills awarded as one of the first batch. Short film "No Problem" or "Something Called" was awarded the "Potential-Level Prize" at the Zhejiang Provincial Brand Story Competition.

9 Ginkgo biloba droplet pills awarded as one of the first batch. Towards Wenling City Shitang Education Foundation Donation 200,000 yuan: Compassionate support for education, paving the way for dreams.

10 Ginkgo biloba droplet pills awarded as one of the first batch. Regarding the clinical study of Huperzine A controlled-release tablets (for Alzheimer's disease indication), it has received approval from the U.S. Food and Drug Administration. FDA ) Feedback, accepting China's Phase 1 clinical data provides insights into key issues for study design. FDA Guidance 。

11 Ginkgo biloba droplet pills awarded as one of the first batch. Chlorpromazine Hydrochloride Tablets have been approved, making this the first domestically produced product to pass the consistency evaluation.

11 Ginkgo biloba droplet pills awarded as one of the first batch. Bedano ® Resorcinol Injection Selected “ 2024 Zhejiang Province's Outstanding Industrial Product of the Year ”。

12 Ginkgo biloba droplet pills awarded as one of the first batch. A novel oral formulation of Huperzine A (R&D product code: WP107 Clinical Trial Application for Treating Generalized Myasthenia Gravis ， Obtaining approval from the U.S. Food and Drug Administration (FDA) FDA) Accepted.

12 Ginkgo biloba droplet pills awarded as one of the first batch. Innovative drug Neostigmine Methyl Injection Product Development Code Name WP103 ) For neonatal hypoxic-ischemic encephalopathy ( HIE )’s clinical trial application for a new indication has been approved by the U.S. Food and Drug Administration ( FDA ) Accepted.

12 Ginkgo biloba droplet pills awarded as one of the first batch. Ranked prominently “2024 Annual Innovation Capability of Zhejiang Province's High-Tech Enterprises 500 Strong ” Ranking list, simultaneously selected “ Top 100 High-Tech Zones for Life and Health ”。